Standout Papers
Immediate Impact
1 from Science/Nature 67 standout
Citing Papers
Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review
2025 Standout
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
Works of Ingrid Holst being referenced
Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial
2019 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ingrid Holst | 318 | 186 | 19 | 87 | 5 | 334 | |
| Vaishali Bhosekar | 270 | 167 | 16 | 81 | 9 | 357 | |
| Maki Goda | 200 | 124 | 18 | 86 | 9 | 352 | |
| Lalita Prasad‐Reddy | 251 | 137 | 11 | 76 | 9 | 360 | |
| Knut Robert Andersen | 329 | 171 | 22 | 58 | 5 | 352 | |
| Surya Panicker Rajeev | 221 | 105 | 17 | 53 | 13 | 272 | |
| Wenying Huang | 219 | 165 | 9 | 58 | 9 | 351 | |
| Thalia Panagiotopoulou | 245 | 97 | 24 | 101 | 3 | 339 | |
| Charlotte C. van Ruiten | 214 | 90 | 20 | 59 | 9 | 263 | |
| Tea Monk Fries | 284 | 148 | 15 | 89 | 7 | 345 | |
| Kristin C. Carlsson Petri | 257 | 116 | 18 | 160 | 10 | 327 |
All Works
Loading papers...